Zydus Lifesciences acquires 6.5 % stake in Mylab via its
subsidiary ZAHIL
Zydus Lifesciences Limited through its wholly owned subsidiary Zydus Animal Health & Investments Limited ( ZAHIL ), has acquired 6.5 % stake in Mylab Discovery Solutions from Rising Sun Holdings , an investment company owned by Adar Poonawalla . The acquisition represents collective vision to transform healthcare by combining therapeutic expertise in human formulations and diagnostic capabilities of the two companies . The synergy through this collaboration will open up new possibilities for advancements in precision medicine , personalized treatments , and preventive care . It will foster innovation , promote cross-disciplinary collaboration , and pave the way for new discoveries and therapies .
Biologic advantage : European pharma sales set to surpass US rivals by 2028 , says GlobalData
The global pharmaceutical industry is experiencing a profound transformation that will shape its future . By 2028 , European pharmaceutical companies are poised to surpass their US counterparts in terms of sales . This transformative shift in global market dynamics is fueled by the rapid growth of biologic sales , which is expected to be a key driver in expanding the overall revenue of the industry , according to GlobalData , a leading data and analytics company .
The changing landscape highlights a remarkable transition in the industry ’ s power dynamics , with four out of the top five companies by total sales expected to hail from Europe .
BioTech
BIOVOICENEWS . COM 11